Randomised Prospective Study of CUSA Versus Radiofrequency Ablation Technique in Liver Resections
NCT ID: NCT06980571
Last Updated: 2025-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2006-06-30
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pre-procedure Planning for Liver Biopsy or Radiofrequency Ablation Using CT or MR/US Fusing Imaging
NCT02967198
Added Value of Contrast-enhanced Ultrasonography for Percutaneous Radiofrequency Ablation
NCT05445973
Pre-procedure Planning for Radiofrequency Ablation Using CT or MR/US Fusion
NCT02687113
A Study of Laparoscopic Hepatectomy Versus RFA in the Treatment of Recurrent HCC
NCT03313648
Radiofrequency Versus Laser Ablation for Hepatocellular Carcinoma
NCT01096914
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Radiofrequency ablation
50 patients randomised to radiofrequency ablation technique of liver resection
radiofrequency ablation
FDA approved intervention being compared with gold standard (most common intervention)
CUSA
50 patients having liver resection randomised to CUSA
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
radiofrequency ablation
FDA approved intervention being compared with gold standard (most common intervention)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barts & The London NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert R Hutchins, MB BS MS FRCS
Role: PRINCIPAL_INVESTIGATOR
Royal London Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal London Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P3/04/Q0605/31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.